Parsifal Capital Management, LP Boston Scientific Corp Transaction History

Parsifal Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $21.7 Million - $26.6 Million	-631,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $8.17 Million - $10.6 Million	270,500 Added 75.03%	631,000 $22.2 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $9.31 Million - $16.5 Million	360,500 New	360,500 $11.8 Million

1,543

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Parsifal Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Parsifal Capital Management, LP with notifications on news.